Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost

Introduction: Respiratory syncytial virus (RSV) bronchiolitis is among the leading causes of hospitalization in infants. Prophylaxis with palivizumab may reduce RSV infection, but its prescription is restricted to high-risk groups. The aim of the study is to retrospectively determine acute hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozzola, Elena, Ciarlitto, Claudia, Guolo, Stefano, Brusco, Carla, Cerone, Gennaro, Antilici, Livia, Schettini, Livia, Piscitelli, Anna Lucia, Chiara Vittucci, Anna, Cutrera, Renato, Raponi, Massimiliano, Villani, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848214/
https://www.ncbi.nlm.nih.gov/pubmed/33537260
http://dx.doi.org/10.3389/fped.2020.594898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848214/
https://www.ncbi.nlm.nih.gov/pubmed/33537260
http://dx.doi.org/10.3389/fped.2020.594898

Ejemplares similares